Urogen Pharma Ltd
NASDAQ:URGN
Urogen Pharma Ltd
Total Other Income
Urogen Pharma Ltd
Total Other Income Peer Comparison
Competitive Total Other Income Analysis
Latest Figures & CAGR of Competitors
Company | Total Other Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Urogen Pharma Ltd
NASDAQ:URGN
|
Total Other Income
-$20.7m
|
CAGR 3-Years
-286%
|
CAGR 5-Years
-180%
|
CAGR 10-Years
N/A
|
|
Collplant Biotechnologies Ltd
NASDAQ:CLGN
|
Total Other Income
-$10k
|
CAGR 3-Years
31%
|
CAGR 5-Years
13%
|
CAGR 10-Years
N/A
|
|
Kamada Ltd
NASDAQ:KMDA
|
Total Other Income
-$980k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
B
|
BioLine RX Ltd
TASE:BLRX
|
Total Other Income
-$10.8m
|
CAGR 3-Years
-24%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Entera Bio Ltd
NASDAQ:ENTX
|
Total Other Income
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
B
|
Bonus Biogroup Ltd
TASE:BONS
|
Total Other Income
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Urogen Pharma Ltd's Total Other Income?
Total Other Income
-20.7m
USD
Based on the financial report for Dec 31, 2023, Urogen Pharma Ltd's Total Other Income amounts to -20.7m USD.
What is Urogen Pharma Ltd's Total Other Income growth rate?
Total Other Income CAGR 5Y
-180%
Over the last year, the Total Other Income growth was 4%. The average annual Total Other Income growth rates for Urogen Pharma Ltd have been -286% over the past three years , -180% over the past five years .